Chadwick Bucur Comment on DEA-319

Document ID: DEA-2009-0002-0004
Document Type: Public Submission
Agency: Drug Enforcement Administration
Received Date: February 19 2009, at 09:33 AM Eastern Standard Time
Date Posted: February 19 2009, at 12:00 AM Eastern Standard Time
Comment Start Date: February 17 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: March 19 2009, at 11:59 PM Eastern Standard Time
Tracking Number: 8085fb42
View Document:  View as format xml

View Comment

If Tapendatol has the same effect such as morphine and oxycodone it most certainly should be placed on Schedule II. Although the drug is new, research has already proven the harmful effects it could have on someone abusing it or just taking a recommended dose. There is no reason for another addictive and life damaging drug to be out on the market and with easy availability.By placing Tapendatol on Schedule II it is the first precautionary step to protecting lives. If Tapendatol has similair physcial and psychological effects of morphine then it just makes sense to put Tapendatol on schedule II. I have seen the effects of morphine personally on a sick relative of mine, it was used as a last result to help dull the severe pain she was going through, but the psychological effects were not worth enduring. Tapendatol must go on schedule II and only be used as a final resort.

Related Comments

   
Total: 3
Chadwick Bucur Comment on DEA-319
Public Submission    Posted: 02/19/2009     ID: DEA-2009-0002-0004

Mar 19,2009 11:59 PM ET
John Coleman Comment on DEA-319
Public Submission    Posted: 03/23/2009     ID: DEA-2009-0002-0006

Mar 19,2009 11:59 PM ET
Ryan York comment on DEA-319
Public Submission    Posted: 03/10/2009     ID: DEA-2009-0002-0005

Mar 19,2009 11:59 PM ET